Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zaroff, C. M.
Right arrow Articles by Kolodny, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zaroff, C. M.
Right arrow Articles by Kolodny, E. H.
Related Collections
Right arrow Metabolic disease (inherited)
Right arrow All Neuropsychology/Behavior
NEUROLOGY 2004;62:2283-2286
© 2004 American Academy of Neurology

Neuropsychological assessment of patients with late onset GM2 gangliosidosis

C. M. Zaroff, PhD, O. Neudorfer, MD, C. Morrison, PhD, G. M. Pastores, MD, H. Rubin, PhD and E. H. Kolodny, MD

From the Department of Neurology, New York University Medical Center, New York.

Address correspondence and reprint requests to Dr. Charles Zaroff, NYU Comprehensive Epilepsy Center, 403 East 34th Street, Rivergate Building 4th Floor, New York, NY 10016; e-mail: Charles.zaroff{at}med.nyu.edu

Objective: To characterize cognitive status in a sample of individuals with late-onset GM2 gangliosidosis (commonly referred to as late-onset Tay-Sachs disease).

Methods: Seventeen subjects (13 men, 4 women) diagnosed with GM2 gangliosidosis were evaluated. Subjects ranged in age from 18 to 56 years and were in various stages of disease progression. Subjects underwent comprehensive neuropsychological assessment. Impairment was defined as performance more than 1.6 SD below the normative mean.

Results: Group mean performance was within the denoted normal range on all measures except on a task assessing visual sequencing and set shifting. Approximately one-half of the sample scored in the impaired range on measures of processing speed, visual sequencing, and set shifting. One-third of the sample also scored in the impaired range on measures of delayed verbal recall. Impairment tended to be restricted to a subset of the sample, as 5 of the 14 subjects able to undergo formal testing accounted for 70% of the total number of impaired scores. If the three subjects unable to participate in formal testing are also considered impaired, 47% of the current sample exhibited significant cognitive impairment in at least one cognitive domain.

Conclusion: In late-onset GM2 gangliosidosis, there is a risk of impairment in executive functioning and memory as well as cerebellar dysfunction. Dementia was not present in any subjects in the current sample.


Received August 6, 2003. Accepted in final form February 17, 2004.




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
M. D. Lauterbach, A. L. Stanislawski-Zygaj, and S. Benjamin
The Differential Diagnosis of Childhood- and Young Adult-Onset Disorders That Include Psychosis
J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 409 - 418.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
G. H. B. Maegawa, T. Stockley, M. Tropak, B. Banwell, S. Blaser, F. Kok, R. Giugliani, D. Mahuran, and J. T.R. Clarke
The Natural History of Juvenile or Subacute GM2 Gangliosidosis: 21 New Cases and Literature Review of 134 Previously Reported
Pediatrics, November 1, 2006; 118(5): e1550 - e1562.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Inglese, A. O. Nusbaum, G. M. Pastores, J. Gianutsos, E. H. Kolodny, and O. Gonen
MR Imaging and Proton Spectroscopy of Neuronal Injury in Late-Onset GM2 Gangliosidosis
AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 2037 - 2042.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. C. Frey, S. P. Ringel, and C. M. Filley
The Natural History of Cognitive Dysfunction in Late-Onset GM2 Gangliosidosis
Arch Neurol, June 1, 2005; 62(6): 989 - 994.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.